Autologous MUC1-activated T-cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Autologous MUC1-activated T-lymphocytes

Filter by location:

Scottsdale, Arizona1 trial

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Mayo Clinic in Arizona

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.